Actinium Pharmaceuticals (Delaware) (ATNM) vs China Pharma (CPHI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Actinium Pharmaceuticals (Delaware) (ATNM) has outperformed China Pharma (CPHI) over the past year, losing 32.3% versus a loss of 56.6%. Over five years, ATNM leads with a -86.7% price change compared with -99.7% for CPHI. China Pharma is the larger company by market cap ($40.0 million vs $33.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATNM | CPHI |
|---|---|---|
| Share price | $1.07 | $0.9301 |
| Market cap | $33.65M | $40.01M |
| 1-day change | +0.04% | +9.42% |
| YTD return | -21.32% | -29.75% |
| 1-year return | -32.28% | -56.63% |
| 5-year return | -86.69% | -99.69% |
| P/E ratio (TTM) | 2.97 | — |
| EPS (TTM) | $0.36 | $-0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.74 | $19.19 |
| 52-week low | $0.735 | $0.38 |
| Distance from 52-week high | -38.48% | -95.15% |
| Average volume | 138.94K | 5.47M |
| Shares outstanding | 31.44M | 43.02M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ATNM has outperformed CPHI by 24.4 percentage points over the past year.
ATNM vs CPHI FAQ
Which is bigger, Actinium Pharmaceuticals (Delaware) or China Pharma?
China Pharma (CPHI) is larger, with a market capitalization of $40.01M compared with $33.65M for Actinium Pharmaceuticals (Delaware) (ATNM).
Which stock has performed better over the past year, ATNM or CPHI?
ATNM returned -32.28% over the past 12 months, compared with -56.63% for CPHI (price return, excluding dividends). Past performance does not predict future results.
Are Actinium Pharmaceuticals (Delaware) and China Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.